Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |